My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 536

    1.

    The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial.

    Recker RR, Davies KM, Dowd RM, Heaney RP.

    Ann Intern Med. 1999 Jun 1;130(11):897-904.PMID: 10375338 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.

    Gallagher JC, Fowler SE, Detter JR, Sherman SS.

    J Clin Endocrinol Metab. 2001 Aug;86(8):3618-28.PMID: 11502787 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip density.

    Gutteridge DH, Holzherr ML, Retallack RW, Price RI, Will RK, Dhaliwal SS, Faulkner DL, Stewart GO, Stuckey BG, Prince RL, Criddle RA, Drury PJ, Tran L, Bhagat CI, Kent GN, Jamrozik K.

    Calcif Tissue Int. 2003 Jul;73(1):33-43.PMID: 14506952 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.

    Grey AB, Stapleton JP, Evans MC, Tatnell MA, Reid IR.

    Ann Intern Med. 1996 Sep 1;125(5):360-8.PMID: 8702086 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effectiveness and safety of vitamin D in relation to bone health.

    Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

    Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.PMID: 18088161 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.

    Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH.

    JAMA. 2002 May 22-29;287(20):2668-76.PMID: 12020302 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone.

    Thiébaud D, Bigler JM, Renteria S, Pache T, Welti HJ, Landry M, Burckhardt P.

    Climacteric. 1998 Sep;1(3):202-10.PMID: 11907945 [PubMed - indexed for MEDLINE]Related articles

    8.

    Bone mineral density response to estrogen replacement in frail elderly women: a randomized controlled trial.

    Villareal DT, Binder EF, Williams DB, Schechtman KB, Yarasheski KE, Kohrt WM.

    JAMA. 2001 Aug 15;286(7):815-20.PMID: 11497535 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial.

    Greenspan SL, Resnick NM, Parker RA.

    JAMA. 2003 May 21;289(19):2525-33.PMID: 12759324 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Postmenopausal femur bone loss: effects of a low dose hormone replacement therapy.

    Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G, Genazzani AR.

    Maturitas. 2003 Jul 25;45(3):175-83.PMID: 12818462 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.

    [No authors listed]

    JAMA. 1996 Nov 6;276(17):1389-96.PMID: 8892713 [PubMed - indexed for MEDLINE]Related articles

    12.

    Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy.

    Alexandersen P, Riis BJ, Stakkestad JA, Delmas PD, Christiansen C.

    J Clin Endocrinol Metab. 2001 Feb;86(2):755-60.PMID: 11158042 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.

    Greenspan SL, Emkey RD, Bone HG, Weiss SR, Bell NH, Downs RW, McKeever C, Miller SS, Davidson M, Bolognese MA, Mulloy AL, Heyden N, Wu M, Kaur A, Lombardi A.

    Ann Intern Med. 2002 Dec 3;137(11):875-83.PMID: 12458987 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.

    Gambacciani M, Ciaponi M, Cappagli B, Genazzani AR.

    Am J Obstet Gynecol. 2001 Nov;185(5):1180-5.PMID: 11717654 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.

    Kaskani E, Lyritis GP, Kosmidis C, Galanos A, Andypas G, Chorianopoulos K, Giagiosis A, Iliadou K, Karagianis A, Katsimichas K, Koskinas A, Matsouka K.

    Clin Rheumatol. 2005 Jun;24(3):232-8. Epub 2005 Jan 13.PMID: 15647969 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women.

    Orr-Walker BJ, Evans MC, Clearwater JM, Horne A, Grey AB, Reid IR.

    Arch Intern Med. 2000 Jul 24;160(14):2161-6.PMID: 10904459 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial.

    Storm D, Eslin R, Porter ES, Musgrave K, Vereault D, Patton C, Kessenich C, Mohan S, Chen T, Holick MF, Rosen CJ.

    J Clin Endocrinol Metab. 1998 Nov;83(11):3817-25.PMID: 9814452 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial.

    Prestwood KM, Kenny AM, Kleppinger A, Kulldorff M.

    JAMA. 2003 Aug 27;290(8):1042-8.PMID: 12941676 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Alveolar and postcranial bone density in postmenopausal women receiving hormone/estrogen replacement therapy: a randomized, double-blind, placebo-controlled trial.

    Civitelli R, Pilgram TK, Dotson M, Muckerman J, Lewandowski N, Armamento-Villareal R, Yokoyama-Crothers N, Kardaris EE, Hauser J, Cohen S, Hildebolt CF.

    Arch Intern Med. 2002 Jun 24;162(12):1409-15. Erratum in: Arch Intern Med. 2004 Jan 12;164(1):96. PMID: 12076241 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women.

    Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH.

    Osteoporos Int. 2005 Apr;16(4):372-9. Epub 2005 Jan 15.PMID: 15654581 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity